Proteomics of SARS-CoV-2]
- Funded by Other funders (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$228,814.66Funder
Other funders (France)Principal Investigator
Julia CHAMOTROOKEResearch Location
FranceLead Research Institution
Institut Pasteur, ParisResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The PROTEO-SARS-CoV-2 project aims to characterize the viral and cellular proteins crucial for infection with the Sars-CoV-2 virus, as well as their interactions and modifications during the infectious mechanism. This will make it possible to isolate possible therapeutic targets that can be exploited to develop future treatments.